Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-20-089710
Filing Date
2020-08-03
Accepted
2020-08-03 17:24:28
Documents
4
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A tm2026459d1_20-fa.htm 20-F/A 31629
2 EXHIBIT 12.1 tm2026459d1_ex12-1.htm EX-12.1 3548
3 EXHIBIT 12.2 tm2026459d1_ex12-2.htm EX-12.2 3886
4 GRAPHIC image_002.jpg GRAPHIC 6113
  Complete submission text file 0001104659-20-089710.txt   48676
Mailing Address 4420 WEST SAANICH ROAD PO BOX 24076 VICTORIA A1 V8Z 6N6
Business Address 4420 WEST SAANICH ROAD PO BOX 24076 VICTORIA A1 V8Z 6N6 1.800.757.3536 X722
Emerald Health Therapeutics Inc. (Filer) CIK: 0001768225 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 333-229744 | Film No.: 201070174
SIC: 2834 Pharmaceutical Preparations